Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
National Resilience Inc.
Headquarters: La Jolla, CA, United States of America
Website: https://resilience.com/
Year Founded: 2020
Status: Private
BioCentury | Oct 1, 2024
Management Tracks
Prothena names Swanson CDO
Plus: Chris Williams at the helm of Culture, GentiBio scoops up former Structure CMO and updates on Burning Rock, National Resilience and Grünenthal
BioCentury | Sep 26, 2024
Finance
Eyes on Europe: Asabys’ €180M fund, Genespire’s record series B
BioCentury’s weekly Venture Report also includes Arch’s latest fund, Flagship-backed Mirai, series Bs for Vicebio and 858, and more
BioCentury | Sep 19, 2024
Management Tracks
EMA names Sepodes CHMP chair, Bell leaving Valo as CEO, and more
Plus: Autolus hires Matthias Will as CDO, and updates from HotSpot, Prilenia, Frazier, BIA and BioCentriq
BioCentury | May 9, 2024
Management Tracks
Reginald Seeto at the helm of Scipher
Plus: New heads of commercial and strategy at AdvanCell, and an update from Vivodyne
BioCentury | Feb 22, 2024
Politics, Policy & Law
Bob Nelsen on AI, China and the IRA
Arch Venture Partners’ co-founder discusses the biotech industry’s challenges and opportunities
BioCentury | Feb 1, 2024
Management Tracks
Rhodes, Manhard join Acadia
Plus: Vivodyne hires Menschik as CTO and an update from Enhanc3D
BioCentury | Jan 2, 2024
Politics, Policy & Law
What to expect from Washington in 2024
An IRA reveal, monumental SCOTUS decisions, new leaders and pathways at FDA
BioCentury | Oct 27, 2023
Management Tracks
Guerard succeeds Baldwin as Opthea’s CEO
Plus: Montai hires its first CMO and an update from Resilience
BioCentury | Oct 3, 2023
Product Development
Oct. 3 Quick Takes: Rare dose of upbeat CD47 data lifts ALX shares
Plus: ODAC prepares to discuss Lumakras and two ‘dangling’ approvals, and updates from Sanofi, Janssen, Biohaven, Resilience, BridgeBio and Surio
BioCentury | Jul 7, 2023
Discovery & Translation
Smaller gene editors, Resilience’s cell-free antibody discovery platform and more
BioCentury’s roundup of translational innovations
Items per page:
1 - 10 of 36